HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Stratigos Selected Research

Tumor Suppressor Protein p14ARF (p14ARF)

6/2008Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Stratigos Research Topics

Disease

9Psoriasis (Pustulosis Palmaris et Plantaris)
06/2020 - 08/2005
7Melanoma (Melanoma, Malignant)
11/2020 - 06/2007
5Mycosis Fungoides
10/2022 - 04/2003
4Neoplasms (Cancer)
12/2019 - 06/2007
3Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2021 - 04/2003
2Basal Cell Carcinoma (Rodent Ulcer)
03/2018 - 04/2014
2Actinic Keratosis
04/2015 - 06/2008
2Rheumatoid Arthritis
02/2012 - 08/2005
1Dermatitis
10/2022
1Pruritus (Itching)
03/2022
1Kidney Neoplasms (Kidney Cancer)
10/2019
1Acute Generalized Exanthematous Pustulosis
03/2019
1Sunburn
07/2018
1Keloid
02/2017
1Hidradenitis
12/2016
1Hidradenitis Suppurativa
12/2016
1Arthritis (Polyarthritis)
05/2010
1Necrosis
03/2010
1Osteitis
07/2009
1Nail Diseases (Nail Disease)
08/2008
1Genomic Instability
06/2008
1Contact Dermatitis (Eczema, Contact)
03/2008
1Disease Susceptibility (Diathesis)
03/2008
1Alopecia Areata
03/2008
1Colonic Neoplasms (Colon Cancer)
01/2008
1Obesity
06/2007
1Ankylosing Spondylitis
08/2005
1Disease Progression
04/2003

Drug/Important Bio-Agent (IBA)

3InterferonsIBA
04/2022 - 04/2003
3Infliximab (Remicade)FDA Link
05/2010 - 08/2005
3Etanercept (Enbrel)FDA Link
08/2009 - 08/2005
2efalizumab (Raptiva)FDA Link
01/2008 - 04/2007
1Mechlorethamine (Nitrogen Mustard)FDA Link
10/2022
1Calcitriol Receptors (Calcitriol Receptor)IBA
11/2021
1serpentine (alkaloid)IBA
11/2020
1Pharmaceutical PreparationsIBA
06/2020
1secukinumabIBA
06/2020
1Antineoplastic Agents (Antineoplastics)IBA
12/2019
1pazopanibFDA Link
10/2019
1Metronidazole (Metric)FDA LinkGeneric
03/2019
1Brentuximab VedotinIBA
01/2019
1Sunscreening Agents (Sunscreens)IBA
07/2018
1sonidegibIBA
03/2018
1Immune Checkpoint InhibitorsIBA
11/2017
1atezolizumabIBA
11/2017
1durvalumabIBA
11/2017
1Fluorouracil (Carac)FDA LinkGeneric
02/2017
1Rifampin (Rifampicin)FDA LinkGeneric
12/2016
1Clindamycin (Cleocin)FDA LinkGeneric
12/2016
1Anti-Bacterial Agents (Antibiotics)IBA
12/2016
1Biological ProductsIBA
08/2016
1betulinIBA
04/2015
1Abatacept (Orencia)FDA Link
02/2012
1Methotrexate (Mexate)FDA LinkGeneric
05/2010
1Monoclonal AntibodiesIBA
05/2010
1AcitretinFDA Link
07/2009
1Ficusin (Psoralen)IBA
02/2009
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
06/2008
1Cyclin-Dependent Kinase Inhibitor p16IBA
06/2008
1AntibodiesIBA
03/2008
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2008
1diphenylcyclopropenoneIBA
03/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2008
1Vitamin DFDA LinkGeneric
01/2008
1Hormones (Hormone)IBA
06/2007
1AdiponectinIBA
06/2007
1Insulin (Novolin)FDA Link
06/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2005
1Theophylline (Theon)FDA LinkGeneric
08/2005
1Ointments (Pastes)IBA
08/2005
1Adalimumab (Humira)FDA Link
08/2005
1InterleukinsIBA
04/2003
1Indicators and Reagents (Reagents)IBA
04/2003
1CytokinesIBA
04/2003
1Interleukin-4 (Interleukin 4)IBA
04/2003

Therapy/Procedure

13Therapeutics
10/2022 - 08/2005
2Immunotherapy
03/2022 - 03/2008
1Aftercare (After-Treatment)
02/2017
1Cryotherapy (Therapy, Cold)
02/2017
1Investigational Therapies (Experimental Therapy)
01/2017
1Secondary Prevention
01/2008
1Lymph Node Excision (Lymph Node Dissection)
08/2007
1Contraindications
04/2007